Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on SAM. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115974717A reveals a cost-effective synthesis for heptafluoroisopropyl bisamides. Discover high-yield routes for reliable agrochemical intermediate supply.
Patent CN106995807A enables high-purity Sitagliptin intermediate synthesis via recombinant transaminase, offering supply chain stability and cost efficiency.
Patent CN104178540B reveals a high-yield E. coli biocatalysis route for Ademetionine, offering superior purity and streamlined manufacturing for global supply chains.
Patent CN108823179A reveals high-efficiency transaminase mutant for R-3-aminobutanol, offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN121204184A reveals high-purity biocatalytic route. Enhanced scalability and cost efficiency for pharmaceutical manufacturing supply chains.
Discover the novel ternary catalyst method for N-ethyl-D-glucosamine production. Achieve higher purity and yield while reducing manufacturing costs and supply chain risks.
Patent CN1095830C details a novel amine exchange method for producing fungicide intermediates, offering improved safety and industrial scalability for agrochemical manufacturers.
Patent CN101285085A reveals a high-efficiency whole cell catalysis method for Adenosylmethionine, offering superior conversion rates and simplified purification for global supply chains.
Novel fragment condensation method for Tesamorelin improves purity and yield. Ideal for pharmaceutical intermediates manufacturing and large-scale production.
Patent CN110358804B reveals high-purity enzymatic resolution for dolutegravir synthesis, offering scalable biocatalysis solutions for reliable pharmaceutical intermediate suppliers.
Novel enzymatic synthesis route for HIV integrase inhibitor intermediates. High purity, scalable process offering significant supply chain stability and cost efficiency for pharmaceutical partners.
Novel enzymatic synthesis route ensures high purity and yield for HIV integrase inhibitor intermediates, offering significant supply chain stability and cost efficiency for global pharmaceutical manufacturers.
Patent CN104761465A reveals a novel route for lacosamide intermediates ensuring high purity and simplified supply chain for global pharmaceutical manufacturing partners.
Advanced one-step resolution technology for high-purity Lacosamide intermediates. Discover cost-effective manufacturing and reliable supply chain solutions for chiral pharmaceutical compounds.
Novel enzymatic synthesis method for high-purity chiral cis-cyclohexanediamine. Scalable process reduces impurities and ensures supply chain reliability for anticoagulant manufacturing.
Patent CN107586796A reveals enzymatic synthesis for high-purity chiral amines. Offers scalable cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN121495896A reveals enhanced enzyme catalysis for chiral amine synthesis offering significant cost reduction and supply chain reliability for agrochemical manufacturing.
Patent CN112930348A details an enzymatic route for Safraninib, improving yield and reducing waste compared to chiral resolution methods.
Patent CN113292495B details a high-yield synthesis of (S)-amino benazepril intermediate using quinine-derived catalysis, offering significant cost and safety advantages for API manufacturing.
Patent CN102850204B details advanced chiral resolution for NSAIDs. Discover cost-effective manufacturing and reliable supply chain solutions for high-purity intermediates.